Trial In Progress: Odronextamab, A Cd20xCd3 Bispecific Antibody, For The Treatment Of Patients With Relapsed/Refractory Marginal Zone Lymphoma (Mzl) - A Cohort From The Elm-2 Study
Odronextamab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Trial In Progress: Odronextamab, A Cd20xCd3 Bispecific Antibody, For The Treatment Of Patients With Relapsed/Refractory Marginal Zone Lymphoma (Mzl) - A Cohort From The Elm-2 Study ### Output: Odronextamab